We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Gastric Bypass Surpasses Gastric Banding for Weight Loss

By HospiMedica International staff writers
Posted on 08 Feb 2012
A new study has found that Roux-en-Y gastric bypass (RYGBP) for bariatric procedures offers more sustainable and rapid weight loss than gastric banding (GB).

Researchers at Centre Hospitalier Universitaire Vaudois (CHUV; Lausanne, Switzerland) conducted a matched-pair study involving 442 patients with a body mass index (BMI) lower than 50 that were matched according to sex, age, and BMI. More...
The surgical procedures, laparoscopic GB or RYGBP, were performed by a common bariatric surgeon. The main outcome measures were operative morbidity, weight loss, residual BMI, quality of life, food tolerance, lipid profile, and long-term morbidity, as evaluated at six years postoperatively.

The results showed that early morbidity was higher after RYGBP (17.2%) than after GB (5.4%), but major morbidity was similar; comorbidities improved more after RYGBP. Weight loss was quicker, maximal weight loss was greater, and weight loss remained significantly better after RYGBP until the sixth postoperative year. At six years, there were more failures--reflected by a BMI higher than 35 or reversal of the procedure--after GB (48.3%) than RYGBP (12.3%). There were also more long-term complications and more reoperations after GB. The study was published early online on January 16, 2012, in Archives of Surgery.

“At the present time, Roux-en-Y gastric bypass seems clearly superior to gastric banding when treating morbidly obese patients, who should be informed accordingly,” concluded lead author Sebastien Romy, MD, and colleagues of the division of endocrinology, diabetology, and metabolism. “The higher early complication rate […] is largely compensated by the much higher long-term complication and reoperation rates seen after gastric banding.”

Bariatric surgery is achieved by reducing the size of the stomach with an implanted medical device (GB), through removal of a portion of the stomach (sleeve gastrectomy or biliopancreatic diversion with duodenal switch) or by resecting and rerouting the small intestines to a small stomach pouch (RYGBP). Long-term studies show the procedures cause significant long-term loss of weight, recovery from diabetes, improvement in cardiovascular risk factors, and a reduction in mortality. In the United States, there is a much greater increase in GB than RYGBP, probably due to the preconception that GB is a "simpler and safer" procedure.

Related Links:
Centre Hospitalier Universitaire Vaudois


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.